Skip to main content

Table 4 Clinical features analysis

From: Genetic and biochemical studies in Argentinean patients with variegate porphyria

 

N° (%) Subjects from

     

Symptomatology

Present Study (n: 72)

South Africaa (n: 269)

Souh Africab (n: 11)

Western Europe c (n: 103)

Finlandd

     

Before 1980 (n: 34)

After 1980 (n: 20)

Acute

20 (28)

51 (19)

0 (0)

20 (20)

10 (29)

3 (15)

Cutaneous

25 (35)

156 (58)

10 (91)

61 (59)

14 (42)

13 (65)

Both

27 (37)

62 (23)

1 (9)

22 (21)

10 (29)

4 (20)

Asymptomatic

15 (29)

31 (10)

17 (61)

----------

19 (36)

30 (60)

Acute

20 (28)

51 (19)

0 (0)

20 (20)

10 (29)

3 (15)

Cutaneous

25 (35)

156 (58)

10 (91)

61 (59)

14 (42)

13 (65)

Both

27 (37)

62 (23)

1 (9)

22 (21)

10 (29)

4 (20)

Asymptomatic

15 (29)

31 (10)

17 (61)

----------

19 (36)

30 (60)

Acute

20 (28)

51 (19)

0 (0)

20 (20)

10 (29)

3 (15)

Cutaneous

25 (35)

156 (58)

10 (91)

61 (59)

14 (42)

13 (65)

Both

27 (37)

62 (23)

1 (9)

22 (21)

10 (29)

4 (20)

Asymptomatic

15 (29)

31 (10)

17 (61)

----------

19 (36)

30 (60)

  1. The total number of symptomatic subjects were considered
  2. a: Eales et al (1980), b: Hift et al, 2004, c: Whatley et al, 1999, d: von und zu Fraunberg et al, 2000.